Narrow search
Showing 1 - 5 of 5
Cover Image
Patenting government funded innovations as a strategy to increase budget for academic vaccine R&D
Songane, Mario - 2019
Persistent link: https://www.econbiz.de/10012138368
Cover Image
The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value
Songane, Mario; Grossmann, Volker - 2020
Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s (WHO) global strategy to fight the disease. However, high vaccine prices...
Persistent link: https://www.econbiz.de/10012269558
Cover Image
The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value
Songane, Mario - 2020
Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization's (WHO) global strategy to fight the disease. However, high vaccine prices...
Persistent link: https://www.econbiz.de/10012825394
Cover Image
The patent buyout price for Human Papilloma Virus (HPV) vaccine and the ratio of R&D costs to the patent value
Songane, Mario; Grossmann, Volker - 2020
Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s (WHO) global strategy to fight the disease. However, high vaccine prices...
Persistent link: https://www.econbiz.de/10012260843
Cover Image
The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value
Songane, Mario; Grossmann, Volker - 2019 - This version: October 2019
Persistent link: https://www.econbiz.de/10012138359